First introduced by Pharmacia & Upjohn in 1999 and known as Aromasin in the field Exemestane is an aromatase inhibitor utilized to treat breast cancer in women who have gone through menopause. This medication is particularly effective, for patients whose cancer progresses after tamoxifen treatment. Being categorized as a suicide inhibitor implies that it permanently binds to and deactivates the aromatase enzyme thus decreasing the production of estrogen. Exemestane is gaining popularity in bodybuilding regimens for managing estrogen related side effects seen during steroid usage, such, as gynecomastia and fluid retention. It is now accessible in over 30 countries all around the world.
Llewellyn, W. (2017). William Llewellyn's Anabolics.
United States: Molecular Nutrition, LLC.
Disclaimer: Information provided it this page is for general information only and does not substitute for professional medical advice.
For detailed information about AROMAMED 25 by Deus Medical, consult with your doctor or healthcare professional.
Llewellyn, W. (2017). William Llewellyn's Anabolics.
United States: Molecular Nutrition, LLC.
Llewellyn, W. (2017). William Llewellyn's Anabolics.
United States: Molecular Nutrition, LLC.
Llewellyn, W. (2017). William Llewellyn's Anabolics.
United States: Molecular Nutrition, LLC.